The company in question is, Neogen Corp. (NASDAQ:NEOG) currently with a stock price of 52.94 (-0.94% today). The market cap for Neogen Corp. is 2014.69, and is in the sector Healthcare, and Diagnostic Substances industry. The target price for Neogen Corp. is 58.25. Currently Neogen Corp. is trading with a P/E of 54.7, and a forward P/E of 41.01. Average volume for Neogen Corp. is 133.66 and so far today it is 25459.
Performance in the last year for Neogen Corp. has been 12.89%. For EPS growth, Neogen Corp. has seen a growth of 7.80%, and is looking to grow in the next year to 16.34%. More long term stats show that EPS growth has been 8.60% over the last five years and could be 16.67% for the next five years. Neogen Corp. has seen sales growth quarter over quarter at 11.60%, with EPS growth quarter over quarter at 4.80%. The 20-day simple moving average is -7.19%, with the 200-day simple moving average coming to 0.46%.
Since the IPO date for Neogen Corp. on the 02/10/1994, Neogen Corp. has seen performance year to date to be -5.45%. With Neogen Corp. trading at 52.94, the dividend yield is *TBA, and the EPS is 0.98.
So could Neogen Corp., be undervalued? Well as said before P/E is 54.7. The PEG is 3.28, P/S is 6.1 and the P/B is at 4.82. The P/cash is 15.59, with P/free cash flow at 58.91.
Neogen Corp. ability to deal with debt shows that the current ratio is 8.2, and the quick ratio is 6.1. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, Neogen Corp. has a gross margin of 47.20%, an operating margin of 17.00% and a profit margin of 11.20%.Payout ratio for Neogen Corp. is 0.00%. Return on assets come to 8.30% with return on investment coming to 9.30%.
Insider ownership for Neogen Corp., is at 2.90% and institutional ownership comes to 87.80%. Outstanding shares are at 37.7. While shares float is 36.36. The float short is currently 2.43%, and short ratio is 6.6.